发明授权
US07718776B2 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors 有权
人抗OPGL中和抗体作为选择性OPGL途径抑制剂

Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
摘要:
Monoclonal antibodies and hybridomas producing them that interact with osteoprotegerin ligand (OPGL) are provided. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are also provided. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are further provided.
信息查询
0/0